NeuroSense Therapeutics stock price
NASDAQ:NRSN · Nasdaq · Healthcare · sector #16$2.56+7.11%Oct 21 close
Loading chart…
NeuroSense Therapeutics's chart data is dated 2026-10-21. There is no active technical signal. The display ticker is NRSN.
NeuroSense Therapeutics last closed at $2.56 (+7.11%) on 2026-10-21. Listed on Nasdaq. Trailing 12 months PER is -0.3×. Its overall grade ranks 493 of 727 stocks in Healthcare.
About this company
NeuroSense Therapeutics last closed at $2.56 (+7.11%) on 2026-10-21. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall C+ · 493/727
Valuation grade B-
About NeuroSense Therapeutics
- What technical signals does NeuroSense Therapeutics (NRSN) have?
- NeuroSense Therapeutics current technical signals: no active technical signal.
- Is NeuroSense Therapeutics a cup-and-handle pattern?
- No. NeuroSense Therapeutics has no valid Cup signal right now.
- What published figures are available for NeuroSense Therapeutics?
- Market cap: $76.03M. Trailing 12 months PER: -0.3×. Latest quarter PBR: -2.10×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about NeuroSense Therapeutics, or open the plan table on the main site.
Ask Q about NeuroSense Therapeutics.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy